EGFR and head and neck squamous cell carcinoma: In the blocking experiments, the tumor uptake of 177Lu-PCTA-cetuximab was markedly reduced by administration of excess cold cetuximab, indicating that 177Lu-PCTA-cetuximab was specifically localized in EGFR expressing SNU-1066 HNSCC xenograft.